Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
TYK Medicines, Inc. Class H ( (HK:2410) ) just unveiled an announcement.
TYK Medicines, Inc, a company listed on the Hong Kong Stock Exchange, has announced a non-compliance incident involving one of its non-executive directors, Dr. Gu Eric Hong. Dr. Gu’s company, Pivot Pharma Tech (Shanghai) Co., Ltd., sold 10,000 H shares during a black-out period without prior notification to the company, reducing his shareholding from 2.20% to 2.19%. The company has responded by reminding its directors and senior management of compliance requirements and plans to provide regular training to prevent future incidents.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 5,192,985
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.07B
See more insights into 2410 stock on TipRanks’ Stock Analysis page.